Skip to content
type1.science
Phase 1RecruitingNCT06708780

Autologous Tregs in T1D

Nanjing Drum Tower Hospital phase 1 study of ex vivo expanded autologous regulatory T cells in people with T1D, revisiting Treg therapy with a modified preparation protocol.

Primary endpoints

  • Adverse events, laboratory abnormalities and other toxicity signals

Results so far

No results posted yet.